Efficacy of the Pan-Bcl-2 Inhibitor (Obatoclax) As a Single Agent to Treat Myeloproliferative Neoplasm in JAK2V617F Murine Transplantation Model

被引：0

作者：

Bianco, Thiago Mantello ^{[1
]}

Coelho-Silva, Juan L. ^{[2
,3
,4
]}

Pereira-Martins, Diego A. ^{[2
,5
]}

Scheucher, Priscila Santos ^{[1
]}

Weinhauser, Isabel ^{[2
]}

Alves Silva, Antonio Bruno ^{[1
,2
]}

Silva, Cleide Lucia ^{[2
]}

Mullally, Ann ^{[6
]}

Kobayashi, Susumu S. ^{[7
,8
]}

Rego, Eduardo M. ^{[2
,9
]}

Traina, Fabiola ^{[1
,2
]}

Figueiredo-Pontes, Lorena Lobo ^{[1
,2
]}

机构：

[1] Univ Sao Paulo, Ribeirao Preto Med Sch, Div Hematol, Dept Med Images Hematol & Clin Oncol, Ribeirao Preto, Brazil

[2] Univ Sao Paulo, Ribeirao Preto Med Sch, Ctr Cell Based Therapy & Reg Hemotherapy Ctr, Ribeirao Preto, SP, Brazil

[3] Univ Sao Paulo, Ribeirao Preto Med Sch, Hematol Div Med Images, Ribeirao Preto, Brazil

[4] Univ Sao Paulo, Ribeirao Preto Med Sch, Clin Oncol Dept, Ribeirao Preto, Brazil

[5] Univ Sao Paulo, Med Sch Ribeirao Preto, Div Hematol, Dept Internal Med, Ribeirao Preto, Brazil

[6] Brigham & Womens Hosp, Div Hematol, 75 Francis St, Boston, MA 02115 USA

[7] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA

[8] Harvard Med Sch, Boston, MA 02115 USA

[9] Univ Sao Paulo, Med Sch, Hosp Clin, Div Hematol,Fac Med HCFMUSP, Sao Paulo, Brazil

来源：

BLOOD | 2019年 / 134卷

关键词：

D O I：

10.1182/blood-2019-131023

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2977

引用

页数：3

共 50 条

[1] Limited Efficacy of BMS-911543 in a Murine Model of JAK2V617F Myeloproliferative Neoplasm
Pomicter, Anthony D.
Eiring, Anna M.
Senina, Anna V.
Marvin, James E.
Prchal, Josef T.
O'Hare, Thomas
Deininger, Michael W.
BLOOD, 2014, 124 (21)
[2] JAK2V617F Mutant Megakaryocytes Contribute to Hematopoietic Aging in a Murine Model of Myeloproliferative Neoplasm
Lee, Sandy
Wong, Helen
Castiglione, Melissa
Murphy, Malea
Kaushansky, Kenneth
Zhan, Huichun
STEM CELLS, 2022, 40 (04) : 359 - 370
[3] JAK2V617F Mutant Megakaryocytes Contribute to Hematopoietic Aging in a Murine Model of Myeloproliferative Neoplasm
Lee, Sandy
Wong, Helen
Castiglione, Melissa
Murphy, Malea
Kaushansky, Kenneth
Zhan, Huichun
BLOOD, 2021, 138
[4] Endothelial JAK2V617F mutation leads to thrombosis, vasculopathy, and cardiomyopathy in a murine model of myeloproliferative neoplasm
Castiglione, Melissa
Jiang, Ya-Ping
Mazzeo, Christopher
Lee, Sandy
Chen, Juei-Suei
Kaushansky, Kenneth
Yin, Wei
Lin, Richard Z.
Zheng, Haoyi
Zhan, Huichun
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 (12) : 3359 - 3370
[5] JAK2V617F mRNA metabolism in myeloproliferative neoplasm cell lines
Nauroy, P.
Delhommeau, F.
Baklouti, F.
BLOOD CANCER JOURNAL, 2014, 4 : e222 - e222
[6] JAK2V617F mRNA metabolism in myeloproliferative neoplasm cell lines
P Nauroy
F Delhommeau
F Baklouti
Blood Cancer Journal, 2014, 4 : e222 - e222
[7] Detection of the JAK2V617F mutation with the Ipsogen MutaScreen kit: absence of JAK2V617F does not mean absence of myeloproliferative neoplasm
Peyro-Saint-Paul, Helene
Hermitte, Fabienne
BLOOD, 2010, 116 (11) : 1994 - 1995
[8] Prevalence of JAK2V617F, CALR in Philadelphia Positive and Negative Myeloproliferative Neoplasm
Abedi, Elham
Karimi, Mehran
Cohan, Nader
Haghpanah, Sezaneh
Yaghobi, Ramin
Azarpira, Negar
Moghadam, Mohamad
Bayat, Elahe
Farokhian, Farnoush
Mohammadi, Hamid
Lak, Elahe Razmara
Golafshan, Habib Allah
Ramzi, Mani
GALEN MEDICAL JOURNAL, 2021, 10
[9] A role for reactive oxygen species in JAK2V617F myeloproliferative neoplasm progression
C Marty
C Lacout
N Droin
J-P Le Couédic
V Ribrag
E Solary
W Vainchenker
J-L Villeval
I Plo
Leukemia, 2013, 27 : 2187 - 2195
[10] A role for reactive oxygen species in JAK2V617F myeloproliferative neoplasm progression
Marty, C.
Lacout, C.
Droin, N.
Le Couedic, J-P
Ribrag, V.
Solary, E.
Vainchenker, W.
Villeval, J-L
Plo, I.
LEUKEMIA, 2013, 27 (11) : 2187 - 2195

← 1 2 3 4 5 →